IGEM Therapeutics is a developer of an immuno-oncology company intended to develop immunoglobulin antibodies to treat cancer.The company's offerings include IgE-based drugs targeting solid tumors, enabling patients to kill parasites which reside in human tissue, also the home of the solid tumor.
Montis Biosciences is a biotechnology company based in Meise, Belgium, focused on developing immune-oncology therapeutics aimed at addressing the relationship between vascular dysfunction and immune suppression in the treatment of solid tumors. Founded in 2020, the company utilizes a target screening and assay platform to identify and develop therapeutic targets that modify the interactions between tumor endothelial cells and perivascular macrophages.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.